Ret-mediated mitogenesis requires Src kinase activity

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1120-1126

  Melillo, Rosa Marina ^a   Barone, Maria Vittoria ^a   Lupoli, Gelsy ^a   Cirafici, Anna Maria ^a   Carlomagno, Francesca ^a   Visconti, Roberta ^a   Matoskova, Brona ^b   Di Fiore, Pier Paolo ^b,c   Vecchio, Giancarlo ^a   Fusco, Alfredo ^c   Santoro, Massimo ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CHIMERA; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE REARRANGEMENT; LIGAND BINDING; MITOGENESIS; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTO ONCOGENE;

3T3 CELLS; ANIMALS; CELL CYCLE; CELL LINE; DROSOPHILA PROTEINS; ENZYME ACTIVATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; KINETICS; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; S PHASE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION;

EID: 0033104338     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Takahashi, M., Buma, Y., Iwamoto, T., Inaguma, Y., Ikeda, H., and Hiai, H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domain. Oncogene. 3: 571-578, 1988.
2. Edery, P., Lyonnet, S., Mulligan, L. M. Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fékété, C., Ponder, B. A. J., and Munnich, A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (Lond.), 367: 378-380, 1994.
3. Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kaarlainen, H., and Martucciello, G. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (Lond.), 367: 377-378, 1995.
4. Pasini, B., Borrello, M. G., Greco, A., Bongarzone, I., Luo, Y., Mondellini, P., Alberti, L., Miranda, C., Arighi, E., Bocciardi, R., Seri, M., Barone, V., Radice, M. T., Romeo, G., and Pierotti, M. Loss of function effect of RET mutations causing Hirschsprung disease. Nat. Genet., 10: 35-40, 1995.
5. Carlomagno, F., De Vita, G., Berlingieri, M. T., de Franciscis, V., Melillo, R. M., Colantuoni, V., Kraus, M. H., Di Fiore, P. P., Fusco, A., and Santoro, M. Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J., 15: 2717-2725, 1996.
6. Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J. C., Hu, S., Altrock, B. W., and Fox, G. M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell, 85: 1113-1124, 1996.
7. Buj-Bello, A., Adu, J., Pinon, L. G. P., Horton, A., Thompson, J., Rosenthal, A., Chinchetru, M., Buchman, V. L., and Davies, A. M. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature (Lond.), 387: 721-724, 1997.
8. Klein, R. D., Sherman, D., Ho, W-H., Stone, D., Bennet, G. L., Moffat, B., Vandlen, R., Simmons, L., Gu, Q., Hongo, J-A., Devaux, B., Poulsen, K., Armanini, M., Nozaki, C., Asai, N., Goddard, A., Phillips, H., Henderson, C. E., Takahashi, M., and Rosenthal, A. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature (Lond.), 387: 717-721, 1997.
9. Jing, S., Yu, Y., Fang, M., Hu, Z., Holst, P. L., Boone, T., Delaney, J., Schulz, H., Zhou, R., and Fox, G. M. GFRα-2 and GFRα-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem., 272: 33111-33117, 1997.
10. Santoro, M., Grieco, M., Melillo, R. M., Fusco, A., and Vecchio, G. Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. Eur. J. Endocr., 133: 513-522, 1995.
11. Pasini, B., Ceccherini, I., and Romeo, G. RET mutations in human disease. Trends Genet., 12: 138-144, 1996.
12. Santoro, M., Melillo, R. M., Grieco, M., Berlingieri, M. T., Vecchio, G., and Fusco, A. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ., 4: 77-84. 1993.
13. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., and Di Fiore, P. P. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (Washington DC). 267: 381-383, 1995.
14. Asai, N., Murakami, H., Iwashita, T., Matsuyama, M., and Takahashi, M. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins. J. Biol. Chem., 271: 17644-17649, 1996.
15. D'Alessio, A., De Vita, G., Cali. G., Nitsch, L., Fusco, A., Vecchio, G., Santelli, G., Santoro, M., and De Franciscis, V. Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. Cell Growth Differ., 6: 1387-1394, 1995.
16. Califano, D., Monaco, C., De Vita, G., D'Alessio, A., Dathan, N. A., Possenti, R., Vecchio, G., Fusco, A., Santoro, M., and de Franciscis, V. Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. Oncogene, 11: 107-112, 1995.
17. Califano, D., D'Alessio, A., Colucci-D'Amato, G. L., De Vita, G., Monaco, C., Santelli, G., Di Fiore, P. P., Vecchio, G., Fusco, A., Santoro, M., and de Franciscis, V. A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc. Natl. Acad. Sci. USA, 93: 7933-7937, 1996.
18. Pawson, T., and Scott, J. D. Signaling through scaffold, anchoring, and adaptor proteins. Science (Washington DC), 278: 2075-2080, 1997.
19. Santoro, M., Wong, T. W., Aroca, P., Santos, E., Matoskova, B., Grieco, M., Fusco, A., and Di Fiore, P. P. An epidermal growth factor receptor/ret chimera generales mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol. Cell. Biol., 14: 663-675, 1994.
20. Borrello, M. G., Alberti, L., Arighi, E., Bongarzone, I., Battistini, C., Bardelli, A., Pasini, B., Piutti, C., Rizzetti, M. G., Mondellini, P., Radice, M. T., and Pierotti, M. A. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol. Cell. Biol., 16: 2151-2163, 1996.
21. Borrello, M. G., Pelieci, G., Arighi, E., De Filippis, L., Greco, A., Bongarzone I., Rizzetti, M., Pelicci, P. G., and Pierotti, M. A. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene. 6: 1661-1668, 1994.
22. van Weering, D. H. J., Medema, J. P., van Puijenbroek, A., Burgering, B. M. T., Baas, P. D., and Bos, J. L. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. Oncogene, 11: 2207-2214, 1995.
23. Pandey, A., Duan, H., Di Fiore, P. P., and Dixit, V. M. The Ret receptor protein tyrosine kinase associates with the SH2-containing adaptor protein Grb10. J. Biol. Chem., 37: 21461-21463, 1995.
24. Pandey, A., Liu, X., Dixon, J. E., Di Fiore, P. P., and Dixit, V. M. Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adaptor protein Grb7. J. Biol. Chem., 18: 10607-10610, 1996.
25. Durick, K., Wu, R-Y., Gill, G. N., and Taylor, S. S. Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain. J. Biol. Chem., 271: 12691-12694, 1996.
26. Durick, K., Gill, G. N., and Taylor, S. S. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mol. Cell. Biol., 18: 2298-2308, 1998.
27. 2-terminal protein kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene, 16: 2435-2445, 1998.
28. Cooper, J. A., and Howell, B. The when and how of Src regulation. Cell, 73: 1051-1054, 1993.
29. Huang, M. M., Indik, Z., Brass, L. F., Hoxie, J. A., Schreiber, A. D., and Brugge, J. S. Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII. J. Biol. Chem., 267: 5467-5473, 1992.
30. Kypta, R. M., Goldberg, Y., Ulug, E. T., and Courtneidge, S. A. Association between the PDGF receptor and members of the Src family of tyrosine kinases. Cell, 62: 481-492, 1990.
31. Courtneidge, S. A., Dhand, R., Pilat, D., Twamley, G. M., Waterfield, M. D., and Roussel, M. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J., 12: 943-950, 1993.
32. c-src with two major signaling pathways in human breast cancer. Proc. Natl. Acad. USA, 91: 83-87, 1994.
33. Muthuswami, S. K., and Muller, W. J. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene, 11: 271-279, 1995.
34. Twamley, G. M., Kypta, R. M., Hall, B., and Courtneidge, S. A. Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. Oncogene, 7: 1893-1901, 1992.
35. Erpel, T., Alonso, G., Roche, S., and Courtneidge, S. A. The SrcSH3 domain is required for DNA synthesis induced by platelet-derived growth factor and epidermal growth factor. J. Biol. Chem., 28: 16807-16812, 1996.
36. Broome, M. A., and Hunter, T. Requirement for c-Src catalytic activity and the SH3 domain in by platelet-derived growth factor BB and epidermal growth factor mitogenic signaling. J. Biol. Chem., 28: 16798-16806, 1996.
37. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Porta, G., Fusco, A., and Vecchio, G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 60: 557-563, 1990.
38. Carlomagno, F., Melillo, R. M., Visconti, R., Salvatore, G., De Vita, G., Lupoli, G., Yu, Y., Jing, S., Vecchio, G., Fusco, A., and Santoro, M. Glial cell line-derived neurotrophic factor differentially stimulates Ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease. Endocrinology, 139: 3613-3619, 1998.
39. Fusco, A., Berlingieri, M. T., Di Fiore, P. P., Portella, G., Grieco, M. and Vecchio, G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol. Cell. Biol., 7: 3365-3370, 1987.
40. Portella, G., Salvatore, D., Botti, G., Cerrato, A., Zhang, L., Mineo, A., Chiappetta, G., Santelli, G., Pozzi, L., Vecchio, G., Fusco, A., and Santoro, M. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTCI oncogene. Oncogene. 13: 2021-2026, 1996.
41. Ball, R. K., Friis, R. R., Schoenenberger, C. A., Doppler, W., and Groner, B. Prulactin regulation of beta-casein gene expression and of a cytosolic 120-Kd protein in a cloned mouse mammary epithelial cell line. EMBO J., 7: 2089-2095, 1988.
42. 1/S arrest. Genes Dev., 8: 453-464, 1994.
43. Barone, M. V., and Courtneidge, S. A. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature (Lond.), 378: 509-512, 1995.
44. Liu, X., Vega, Q. C., Decker, R. A., Pandey, A., Worby, C. A., and Dixon, J. E. Oncogenic RET receptors display different autuphosphorylation sites and substrate binding specificities. J. Biol. Chem., 271: 5309-5312, 1996.
45. Arighi, E., Alberti, L., Torriti, F., Ghizzoni, S., Rizzetti, M. G., Pelicci, G., Pasini, B., Bongarzone, I., Piutti, C., Pierotti, M. A., and Borrello, M. G. Identification of Shc docking site on Ret tyrosine kinase. Oncogene. 14: 773-782, 1997.
46. Lorenzo, M. J., Gish, G. D., Houghton, C., Stonehouse, T. J., Pawson, T., Ponder, B. A. J., and Smith, D. P. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2. Oncogene, 14: 763-771, 1997.
47. Songyang, Z., Shoelson, S. E., Chauduri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofski, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C. SH2 domains recognize specific phosphopeptide sequences. Cell, 72: 767-778, 1993.
48. Roche, S., Koegl, M., Barone, M. V., Roussel, M., and Courtneidge, S. A. DNA synthesis induced by some, but not all, growth factors requires Src family protein tyrosine kinases. Mol. Cell. Biol., 15: 1102-1109, 1995.
49. Kremer, N. E, D'arcangelo, G., Thomas, S. M., DeMarco, M., Brugge, J. S., and Halegoua, S. Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of Src and Ras action. J. Cell Biol., 115, 809-819, 1991.
50. Durik, K., Yao, V. J., Borrello, M. G., Pierotti, N. A., and Taylor, S. S. Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/PTC2. J. Biol. Chem., 42: 24642-24645, 1995.
51. Rosen, N., Bolen, J. B., Schwartz, A. M., Cohen, P., DeSeau, V., and Israel, M. A. Analysis of pp60 c-Src protein kinase activity in human tumor cell lines and tissues. J. Biol. Chem., 261: 13754-13759, 1986.
52. Cartwright, C. A., Kamps, M. P., Meisler, A. I., Pipas, J. M., and Eckart, W. pp60c-Src activation in human colon carcinoma. J. Clin. Invest., 83: 2025-2033, 1989.
53. Jacobs, C., and Rubsamen, H. Expression of pp60 c-Src in adult and fetal human tissues: high activities in some sarcomas and mammary carcinomas. Cancer Res., 43: 1696-1702, 1983.
54. Ottenholf-Kalff, A. E., Rijksen, G., van Beurden, E. A. C. M., Hennipman, A., Michels, A. A., and Staal, G. E. J. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-Src oncogene product. Cancer Res., 52: 4773-4778, 1992.
55. Muthuswami, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., and Muller, W. J. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol., 14: 735-743, 1994.
56. Mao, W., Irby, R., Coppola, D., Fu, L., Wloch, M., Turner, J., Yu, H., Garcia, R., Jove, R., and Yeatman, T. J. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene. 15: 3083-3090, 1997.
57. Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., Schlessinger, J., and Aaronson, S. A. ErbB-2 is a potent oncogene when overexpressed in NIH-3T3 cells. Science (Washington DC), 237: 178-181, 1987.
58. Di Fiore, P. P., Segatto, O., Taylor, W. G., Aaronson, S. A., and Pierce, J. H. EGF receptor and erb-B2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science (Washington DC), 248: 79-83, 1990.